Crossmark

ASO Author Reflections: Avoiding an Axillary Lymph Node Dissection: The Benefit of Neoadjuvant Chemotherapy for Occult Primary Breast Cancer

Published Online: 2020-07-28

Published Print: 2020-12

Authors

Botty van den Bruele, Astrid

Plitas, George

Pilewskie, Melissa
License Information

Text and Data Mining valid from 2020-07-28

Version of Record valid from 2020-07-28
More Information

Article History

Received: 13 July 2020

Accepted: 14 July 2020

First Online: 28 July 2020

Disclosures

: Dr. George Plitas reports scientific advisory board participation with Merck and Tizona Therapeutics, and research funding from Takeda Pharmaceuticals.

Document is current